Table 2.
HPV Vaccine Series Completion Rate by Recommended Dose
| Completed recommended dose | Timely completion of recommended dose | |||
|---|---|---|---|---|
| Group | n/N | % | n/N | % |
| All patients | 1,961/3,044 | 64.4% | 1,637/3,044 | 53.8% |
| Recommended 2 dosesa | 1,918/2,961 | 64.8% | 1,598/2,961 | 54.0% |
| Recommended 3 doses | 43/83 | 51.8% | 39/83 | 47.0% |
Notes: Timely completion of recommended dose indicates the adolescent completed recommended vaccine doses within 14-months. N=Subjects with data available for the analysis.
a
Includes 5 adolescents who were recommended 2 doses but received 3 doses.
HPV, human papillomavirus.